- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04638413
Cognitive Training Through Gaming and Walking
November 4, 2025 updated by: Sarah Salvy, Cedars-Sinai Medical Center
This pilot study evaluated the feasibility of combining daily walking and gamified inhibitory control training.
Feasibility was defined by recruitment, retention, and adherence to arm requirements, with secondary, exploratory analyses examining cognitive function outcomes
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This pilot study evaluated the feasibility of combining a walking regimen with gamified inhibitory control training (PolyRules!), compared to walking alone, on cognitive outcomes among healthy adults (ages 18 and over).
Participants (n=30) will first be asked to wear a Fitbit for one week to capture baseline activity.
Participants will then be randomized to (1) walking alone regimen or (2) walking + gamified inhibitory control training for three weeks.
Cognitive assessments will be conducted at enrollment and at the end of the 4-week study protocol.
The primary outcome of the pilot trial is feasibility as defined by recruitment, retention, and adherence to arm requirements.
Engagement and adherence will be operationalized as the frequency and duration of cognitive training passively recorded on the PolyRules!
app and frequency and duration of walking as monitored by Fitbit data.
Secondary outcomes examined cognitive function outcomes performance: changes in attention and inhibitory control [Cancellation task, Flanker task, and Rule Set task]; And working memory capacity [N-Back task, Letter-Numbers task, and Corsi task].
Qualitative indicators will also be collected via semi-structured interviews to capture participants' satisfaction, perceived benefits of- and/or barriers to engaging with the cognitive training and/or walking regimens.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Able to read, write, and speak English with acceptable visual and auditory acuity, as the app is only available in English
- Able and willing to walk independently with or without walking aids
- Able and willing to engage in 30 minutes of walking daily
- Able and willing to wear a fitness tracking device (e.g. Fitbit)
- Not currently engaging in a daily walking regimen of 30 minutes or more a day
Exclusion Criteria:
- Visual impairments that would preclude participants from using the app
- Undergoing active cancer treatment
- Diagnosis of peripheral neuropathy, severe musculoskeletal or neurodegenerative disease (e.g. dementia, multiple sclerosis, Parkinson's disease, Huntington's disease, etc.)
- Taking medications that may affect cognitive function
- Pacemaker, implantable cardiac defibrillator, neuro-stimulation devices, cochlear implants, implantable hearing aids, or other electronic medical equipment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Walking regimen (W)
|
Participants engage in 30 min of walking daily, for three weeks.
|
|
Experimental: Walking regimen + gamified inhibitory control training (W+PolyRules!)
|
Participants alternate between 30 min of walking on half of the days and 30 min of gamified inhibitory control on the other days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment and Retention
Time Frame: Immediately after the 4 week study
|
Percentage of randomized participants who complete the final study visit/assessment at the end of the intervention period.
Completion is defined as providing primary outcome data (objective adherence logs), calculated as (number completing final assessment / number randomized) × 100.
|
Immediately after the 4 week study
|
|
Rate of walking regimen completion
Time Frame: Daily starting at baseline and for 4 continuous weeks
|
Activity will be continuously recorded by the Fitbit to monitor whether participants engage in daily physical activity.
There are a total of 9 and 18 walking sessions that may be completed for participants assigned to the control group and intervention group, respectively.
Competing one of the sessions entails completing 30 minutes of walking with a wearable.
A ratio of completion will be calculated using the number of walking sessions completed over the total amount of sessions possible.
|
Daily starting at baseline and for 4 continuous weeks
|
|
Rate of gamified cognitive training completion
Time Frame: Daily starting at baseline and for 4 continuous weeks
|
Participants' interactions with the app (PolyRules!) will be passively recorded by the software to monitor training session completion.
There are a total of 8 or more sessions that may be completed for participants assigned to the condition.
Competing one of the sessions entails completing 30 minutes of cognitive training session using the application.
A ratio of completion will be calculated using the number of sessions completed over the total amount of sessions possible.
|
Daily starting at baseline and for 4 continuous weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Flanker Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
The Flanker Task tests selective attention and inhibitory control.
Participants are presented with a row of arrows and are asked whether the centrally presented arrow is pointing either to the left or to the right.
In the congruent trials, the non-target arrows point in the same direction as the target arrow and in the incongruent trials they point in the opposite direction.
The stimuli are presented in a pseudo-random order in which neither the trial type nor the trial direction can repeat more than three times in a row.
Each condition is presented 12 times resulting in 48 total trials.
The row of arrows is presented for 500ms with a 500ms break.
The location of the row is randomly jittered so that it appears in one of 9 possible locations to prevent participants from fixating their gaze on the location of the central arrow.
The user has 15 seconds to choose a response from the moment a trial is presented.
Participants should respond as quickly and accurately as possible.
|
At baseline; Immediately after the 4-week study
|
|
Change in Rule Switch Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
The Rule Switch Task is a tablet-based measure of inhibitory control modeled after standard rule switching tasks such as the NIH Examiner (Kramer et al, 2014).
In this task, participants must match the stimulus at the top of the screen (either a red or blue circle or square) by selecting one of the buttons (i.e., a red square or blue circle).
Participants are instructed to classify the shape by one of two rules, either shape or color.
There are 24 color trials and 24 shape trials, half of one shape and half of the other, for a total of 48 trials.
There are three variables: shape, color and trial type.
The three variables are pseudo-randomly intermixed so that any subset of 5 consecutive trials cannot have one of those traits in common across all 5 trials (no more than 4 trials in a row can share any of the three variable traits in common).
There is also a switch rule in that there need to be a minimum of two trials of the same type before switching to a different trial type.
|
At baseline; Immediately after the 4-week study
|
|
Change in Cancellation Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
The Cancellation Task is a timed, tablet-based test of selective attention and inhibitory control, akin to D2 (Brickenkamp & Zilmer, 1998).
There are two versions that can be used interchangeably: Cancellation Letters and Cancellation Pictures.
Cancellation - Letters resembles the D2 in that it consists of similar stimuli: characters "d" and "p" with one to four dashes, arranged either individually or in pairs above or below the letters.
For Letters, the participant must scan the items from left to right and select all "d"s with two dashes (targets).
In Cancellation - Pictures, letters are replaced with pictures of dogs and monkeys, some of which are rotated along the vertical axis or are presented upside down.
For Pictures, the participant must select the upright dog (tail on the left) and the upside-down monkey (tail on right) separately in single blocks and together in a mixed block.
|
At baseline; Immediately after the 4-week study
|
|
Change in N-Back Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
In the N-Back task, working memory will be assessed.
Participants are presented with a consecutive stream of pictures, and the objective is to tap on the pictures that match those presented N items earlier.
Higher levels of N levels increase WM load and make the task more difficult.
All participants complete 1-back (Figure 4), 2-back, and 3-back (in that order).
Before each level starts, there is a practice session consisting of 10 trials during which performance feedback is provided.
The test phase for each N-level consists of 30 trials with 9 targets.
Progression to 4-back (and beyond) is allowed if the participant made no more than 2 errors on the previous level.
Stimuli are presented for 2500 ms (participant can respond during this period) with an ISI of 500 ms.
|
At baseline; Immediately after the 4-week study
|
|
Change in Letter-Number Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
In the Letter-Number task, working memory will be assessed.
Participants are presented with a mixed order of letters and numbers, which they must remember and sort them numerically and alphabetically.
For example, the sequence 'H8T3K5' would be sorted into '358' and 'HKT'.
The mixed orders of letter and numbers ranges from 2 to 15.
After a short tutorial, the participant practices the task and must get three out of the five trials correct to proceed to the test.
The Letter Number Task is split into two parts: The first is a method of limits to find the participants threshold, whereas the second provides additional trials around that threshold.
Characters that could be confused with other letters or numbers are excluded (0, I, O, U, X).
Moreover, a given sequence does not include any of the characters in the previous trial and it does not contain consecutive numbers and letters.
|
At baseline; Immediately after the 4-week study
|
|
Change in Corsi Task performance from baseline to 4 weeks
Time Frame: At baseline; Immediately after the 4-week study
|
Visuospatial working memory will be measured with a modified Corsi Task, a collection of 4 types of tasks (i.e.
classic - blocks, simple, complex, sequencing) that are customizable where an experimenter can select which task mode, stimulus type, and algorithm they want to use.
In all versions of the task, the participant is shown instructions and then practices the task.
Corsi Blocks Classic: The participant first completes Corsi Blocks Forward (tap in same order), followed by Corsi Blocks Reverse (tap in reverse order).
The Corsi Blocks Forward task is split into two parts: the first is a method of limits to find the participants threshold, whereas the second provides additional trials around that threshold.
Complex Corsi: Combines Simple Corsi with a secondary sorting task in between each trial.
In the sorting task, the participant must drag a dog to a bone or a monkey to a banana.
The location of the bone and banana are randomized to prevent mnemonic strategies like chunking.
|
At baseline; Immediately after the 4-week study
|
|
Experience with walking regimen and cognitive training
Time Frame: Immediately after the 4-week study
|
Assessed by semi-structured interviews and will include: participants' satisfaction with the app and/or walking regime; perceived benefits of cognitive training and/or walking; and barriers to engaging with the app and/or walking regime.
|
Immediately after the 4-week study
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive functioning
Time Frame: At baseline; Immediately after the 4-week study
|
Assessed using the Behavior Rating Inventory of Executive Function for Adults (BRIEF-A).
|
At baseline; Immediately after the 4-week study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sarah J Salvy, PhD, Cedars-Sinai Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 26, 2022
Primary Completion (Actual)
January 4, 2023
Study Completion (Actual)
February 12, 2025
Study Registration Dates
First Submitted
October 29, 2020
First Submitted That Met QC Criteria
November 16, 2020
First Posted (Actual)
November 20, 2020
Study Record Updates
Last Update Posted (Estimated)
November 5, 2025
Last Update Submitted That Met QC Criteria
November 4, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001030
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Lifestyle
-
Eindhoven University of TechnologyCompletedLifestyle | Lifestyle, Healthy | Lifestyle Risk Reduction | Lifestyle, SedentaryBelgium
-
Buchinger Wilhelmi Development & Holding GmbHKing's College London; Buchinger Wilhelmi Clinic; MVZ Labor Ravensburg GbR; Synlab...CompletedHealthy Lifestyle | Healthy NutritionGermany
-
Mälardalen UniversitySwedish Environmental Research Institute (IVL)Active, not recruitingHealthy Diet | Healthy LifestyleSweden
-
Örebro University, SwedenRecruiting
-
Umeå UniversityRegion VästerbottenActive, not recruiting
-
Igdir UniversityAtaturk UniversityCompleted
-
Princess Nourah Bint Abdulrahman UniversityCompletedHealthy LifestyleSaudi Arabia
-
Royal College of Surgeons, IrelandPrivate Philanthropic FunderCompleted
-
University Rovira i VirgiliErasmus Medical Center; Harokopio University; University of Exeter; Institut Investigacio... and other collaboratorsCompletedHealthy LifestyleSpain, Greece, Netherlands, United Kingdom
-
Dynamical Business and Science Society - DBSS International...CES University; INDEPORTES AntioquiaCompleted
Clinical Trials on Walking (W)
-
University of Sao PauloCompletedChronic Low Back PainBrazil
-
University Institute of MaiaCompletedElderly | Physiological DemandsPortugal
-
GlaxoSmithKlineCompleted
-
Mimetica Pty LimitedUnknownAcne VulgarisUnited States
-
Mimetica Pty LimitedCompleted
-
Aclaris Therapeutics, Inc.CompletedAtopic DermatitisUnited States
-
Amytrx Therapeutics, Inc.Amarex Clinical ResearchCompletedAtopic DermatitisUnited States
-
Hospital dos Servidores do Estado do Rio de JaneiroCompletedRecurrent MiscarriageBrazil
-
Pharma Holdings ASUniversity Hospital of North NorwayCompleted
-
Zai Lab (Hong Kong), Ltd.Zai Lab (US) LLCRecruiting